A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...
Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...
Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback